• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Introduction to 5-Bromo-3-cyclopropyl-1H-indazole (CAS No. 911305-80-1)

5-Bromo-3-cyclopropyl-1H-indazole, identified by the Chemical Abstracts Service Number (CAS No.) 911305-80-1, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the indazole class, characterized by a fused benzene and pyrrole ring system, with functional modifications that enhance its biological activity and potential therapeutic applications.

The structural motif of 5-Bromo-3-cyclopropyl-1H-indazole consists of a bromine substituent at the 5-position and a cyclopropyl group at the 3-position of the indazole core. These specific substituents are strategically positioned to modulate the electronic properties and steric interactions of the molecule, thereby influencing its binding affinity to biological targets. The presence of the bromine atom, in particular, makes this compound a valuable scaffold for further derivatization and optimization in drug discovery programs.

In recent years, indazole derivatives have been extensively studied due to their diverse pharmacological activities. These compounds exhibit a broad spectrum of biological effects, including antimicrobial, anti-inflammatory, antiviral, and anticancer properties. The structural features of 5-Bromo-3-cyclopropyl-1H-indazole contribute to its potential as an intermediate in the synthesis of novel therapeutic agents targeting various diseases.

One of the most compelling aspects of 5-Bromo-3-cyclopropyl-1H-indazole is its utility as a building block in medicinal chemistry. The bromine atom at the 5-position provides a reactive site for cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, which are commonly employed in the construction of complex molecular architectures. Similarly, the cyclopropyl group at the 3-position can serve as a handle for further functionalization, allowing chemists to explore diverse chemical space.

The synthesis of 5-Bromo-3-cyclopropyl-1H-indazole typically involves multi-step organic transformations starting from readily available precursors. The introduction of the bromine atom can be achieved through halogenation reactions, while the incorporation of the cyclopropyl group often requires ring-closing metathesis or other cyclopropanation strategies. These synthetic routes highlight the compound's versatility and its suitability for industrial-scale production.

Recent advances in computational chemistry have further enhanced the understanding of 5-Bromo-3-cyclopropyl-1H-indazole's reactivity and biological interactions. Molecular modeling studies have revealed that this compound can effectively bind to target proteins through specific hydrogen bonding networks and hydrophobic interactions. Such insights are crucial for designing next-generation drugs with improved efficacy and reduced side effects.

The pharmacological profile of 5-Bromo-3-cyclopropyl-1H-indazole has been explored in several preclinical studies. These investigations have demonstrated its potential in inhibiting key enzymes and receptors involved in cancer progression. For instance, studies suggest that this compound may interfere with tyrosine kinase activity, which is often dysregulated in malignant tumors. Additionally, its ability to modulate immune responses has been investigated as a possible strategy for developing immunotherapeutic agents.

Beyond its applications in oncology, 5-Bromo-3-cyclopropyl-1H-indazole has shown promise in addressing other therapeutic areas. Research indicates that this compound exhibits anti-inflammatory effects by inhibiting pro-inflammatory cytokines and chemokines. This makes it a candidate for developing treatments for chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The safety profile of 5-Bromo-3-cyclopropyl-1H-indazole is another critical consideration in its development as a drug candidate. Preliminary toxicology studies have evaluated its acute and chronic toxicity profiles, providing valuable data on its potential side effects. These assessments are essential for ensuring that any future drug candidates derived from this scaffold are safe for human use.

In conclusion, 5-Bromo-3-cyclopropyl-1H-indazole (CAS No. 911305-80-1) represents a promising compound in pharmaceutical research due to its unique structural features and biological activities. Its potential applications span multiple therapeutic areas, making it an attractive scaffold for further drug development. As research continues to uncover new insights into its mechanisms of action, this compound is poised to play a significant role in advancing modern medicine.

• 199172-01-5(6-Bromo-3-ethyl-1H-indazole)
• 61485-22-1(1H-Indazole, 3-(1-methylpropyl)-)
• 864774-67-4(5-Bromo-3-ethyl-1H-indazole)
• 1197943-62-6(5-Bromo-3-propyl-1H-indazole)
• 61485-21-0(1H-Indazole, 3-(2-methylpropyl)-)
• 61485-20-9(1H-Indazole, 3-butyl-)
• 61485-18-5(3-propyl-1H-Indazole)
• 61485-19-6(3-(1-methylethyl)-1H-Indazole)
• 1311197-86-0(6-Bromo-3-cyclopropyl-1-methylindazole)
• 693285-71-1(4-bromo-3-(propan-2-yl)-1H-indazole)